Atlas Trials

Yihao Wang

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Yihao Wang

RecordFirmDate
An Open-label, Single-arm, Prospective, Multicenter, Phase I/II Clinical Study on the Safety and Efficacy of CD19/BCMA CAR-T Cell Therapy for Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia (NCT07324889)Yihao Wang2026-01-31

Track Yihao Wang automatically

Every clearance here is in the API, with alerts when new ones post.